| dc.creator | Neonakis, I. K. | en |
| dc.creator | Spandidos, D. A. | en |
| dc.creator | Petinaki, E. | en |
| dc.date.accessioned | 2015-11-23T10:40:53Z | |
| dc.date.available | 2015-11-23T10:40:53Z | |
| dc.date.issued | 2011 | |
| dc.identifier | 10.1016/j.ijantimicag.2010.10.014 | |
| dc.identifier.issn | 0924-8579 | |
| dc.identifier.uri | http://hdl.handle.net/11615/31338 | |
| dc.description.abstract | Multidrug-resistant Acinetobacter baumannii (MDR-AB) infections are difficult to treat owing to the extremely limited armamentarium. The present review reports all available treatment options against MDR-AB, including single molecules, combination schemes, and alternative modes of antimicrobial administration. Additionally, a group of recently reported peptides with anti-MDR-AB activity is described. (C) 2010 Elsevier B. V. and the International Society of Chemotherapy. All rights reserved. | en |
| dc.source.uri | <Go to ISI>://WOS:000286198900002 | |
| dc.subject | Acinetobacter baumannii | en |
| dc.subject | Tigecycline | en |
| dc.subject | Peptides | en |
| dc.subject | Colistin | en |
| dc.subject | Rifampicin | en |
| dc.subject | Minocycline | en |
| dc.subject | VENTILATOR-ASSOCIATED PNEUMONIA | en |
| dc.subject | IN-VITRO ACTIVITY | en |
| dc.subject | GRAM-NEGATIVE | en |
| dc.subject | BACTERIA | en |
| dc.subject | INTENSIVE-CARE-UNIT | en |
| dc.subject | SUSCEPTIBILITY TESTING METHODS | en |
| dc.subject | BLOOD-STREAM INFECTION | en |
| dc.subject | PSEUDOMONAS-AERUGINOSA | en |
| dc.subject | INTRAVENOUS COLISTIN | en |
| dc.subject | NOSOCOMIAL INFECTIONS | en |
| dc.subject | POLYMYXIN-B | en |
| dc.subject | Infectious Diseases | en |
| dc.subject | Microbiology | en |
| dc.subject | Pharmacology & Pharmacy | en |
| dc.title | Confronting multidrug-resistant Acinetobacter baumannii: a review | en |
| dc.type | journalArticle | en |
